Tananbaum James B. made 15 transactions for Latigo Biotherapeutics, Inc. ($LTGO) on Aug 11, 2026 | Average Insider

Latigo Biotherapeutics, Inc. ($LTGO)

Accession: 0001581754-26-000006

Aug 11, 2026

📈 Chart on TradingView 💰 Financials on Finviz

52W Low$17.22

Current$19.3841.0% above low, 59.0% below high

52W High$22.47

Filing Information

Accession Number	0001581754-26-000006
Form Type	4
Filing Date	Aug 11, 2026
Document	View SEC Filing

Transactions

15

Total Shares

18,222,656

Total Value

$2,520,000.00

P&L

+7.6% (+$192,500.00)

Transactions

Name	Title	Security	Derivative	Transaction Date	Type	Shares	Price	Total Cost	Shares After	Direct/Indirect	Nature of Ownership	Actions
Tananbaum James B.	Director	Common Stock	—	Aug 10, 2026	Conversion	3,117,664	—	—	3,117,664	Indirect	See footnote	View Details
Tananbaum James B.	Director	Common Stock	—	Aug 10, 2026	Conversion	445,320	—	—	3,562,984	Indirect	See footnote	View Details
Tananbaum James B.	Director	Common Stock	—	Aug 10, 2026	Conversion	1,125,823	—	—	1,125,823	Indirect	See footnote	View Details
Tananbaum James B.	Director	Common Stock	—	Aug 10, 2026	Conversion	742,201	—	—	1,868,024	Indirect	See footnote	View Details
Tananbaum James B.	Director	Common Stock	—	Aug 10, 2026	Purchase	140,000	$18.00	$2,520,000.00	2,008,024	Indirect	See footnote	View Details
Tananbaum James B.	Director	Common Stock	—	Aug 10, 2026	Conversion	195,776	—	—	2,203,800	Indirect	See footnote	View Details
Tananbaum James B.	Director	Common Stock	—	Aug 10, 2026	Conversion	3,117,664	—	—	3,117,664	Indirect	See footnote	View Details
Tananbaum James B.	Director	Common Stock	—	Aug 10, 2026	Conversion	296,880	—	—	3,414,544	Indirect	See footnote	View Details
Tananbaum James B.	Director	Series A-2 Convertible Stock (Common Stock)	Derivative	Aug 10, 2026	Conversion	3,117,664	—	—	0	Indirect	See footnote	View Details
Tananbaum James B.	Director	Series B Convertible Preferred Stock (Common Stock)	Derivative	Aug 10, 2026	Conversion	445,320	—	—	0	Indirect	See footnote	View Details
Tananbaum James B.	Director	Series A-2 Convertible Preferred Stock (Common Stock)	Derivative	Aug 10, 2026	Conversion	1,125,823	—	—	0	Indirect	See footnote	View Details
Tananbaum James B.	Director	Series B Convertible Preferred Stock (Common Stock)	Derivative	Aug 10, 2026	Conversion	742,201	—	—	0	Indirect	See footnote	View Details
Tananbaum James B.	Director	Series A-2 Convertible Preferred Stock (Common Stock)	Derivative	Aug 10, 2026	Conversion	3,117,664	—	—	0	Indirect	See footnote	View Details
Tananbaum James B.	Director	Series B Convertible Preferred Stock (Common Stock)	Derivative	Aug 10, 2026	Conversion	296,880	—	—	0	Indirect	See footnote	View Details
Tananbaum James B.	Director	Convertible Promissory Note (Common Stock)	Derivative	Aug 10, 2026	Conversion	195,776	—	—	0	Indirect	See footnote	View Details

Version: v26.7.3